VVOS
Vivos Therapeutics IncNASDAQ
Healthcare • Medical Devices
Updated 1 day ago
Coverage ready
$0.14-1.80%
Close Oct 13, 2026
- Market cap
- $2.5M
- 1 month
- -19.9%
- 3 months
- -65.7%
- 1 year
- -95.5%
- 52-week range
- $0.13$3.18
- Dividend
- No dividends on record
- Next-quarter EPS estimate
- -$0.30Quarter to Sep 30, 2026 · 4 analysts · revenue $5.48M
- Short interest
- 15.0% of float2.9M shares · settled Sep 30, 2026 · +76.1% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $20.9M
- Net income
- -$25.59M
- Free cash flow
- -$18.56M
- Book value
- —
- Total debt
- $12.14M
- P/E
- —
- Price / sales
- 0.1×
- Price / book
- —
- FCF yield
- -741.3%
- Net margin
- -122.4%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if VVOS is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
0 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 11
Largest 13-F holders · Q2 2026
22 filers reported a long position in VVOS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $38.6K | 85K | -11% |
| IHT Wealth Management, LLC | $34.9K | 76.7K | +86.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | $27.6K | 60.6K | -77.8% |
| COMMONWEALTH EQUITY SERVICES, LLC | $19.3K | 42.5K | Unchanged |
| B. Riley Wealth Advisors, Inc. | $18.8K | 38.1K | Unchanged |
| UBS Group AG | $17.8K | 39.2K | +254.5% |
| Centurion Wealth Management LLC | $16.2K | 35.7K | Unchanged |
| BlackRock, Inc. | $12.6K | 27.8K | Unchanged |
| STATE STREET CORP | $11.3K | 24.9K | Unchanged |
| Sequoia Financial Advisors, LLC | $10.9K | 24K | Unchanged |
Get the Full Analysis for VVOS
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.